Back to Search
Start Over
Incremental Hemodialysis: What We Know so Far
- Source :
- International Journal of Nephrology and Renovascular Disease, Vol Volume 15, Pp 161-172 (2022)
- Publication Year :
- 2022
- Publisher :
- Dove Medical Press, 2022.
-
Abstract
- Vivek Soi,1,2 Mark D Faber,1,2 Ritika Paul1 1Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI, USA; 2Wayne State University School of Medicine, Detroit, MI, USACorrespondence: Vivek Soi, Email vsoi1@hfhs.orgAbstract: Traditionally, patients that develop progressive chronic kidney disease in need of kidney replacement therapy are prescribed thrice weekly in-center hemodialysis sessions at the beginning of therapy. This empiric prescription is based on historic trials that were comprised of mostly prevalent patients. Incremental hemodialysis is the process of performing < 3 sessions of dialysis per week or limiting dialysis dose by duration at the initial onset of treatment to provide a more gradual transition, mimicking the progressive nature of kidney disease. Adding clearance contributions from residual kidney function is the standard of care with peritoneal dialysis but has not routinely been employed with hemodialysis. Accounting for residual kidney function accompanied by improvement in adjuvant pharmacotherapy, such as newer potassium binding agents and dietary modification, can augment dialytic clearances and allow for an incremental approach. Utilizing incremental dialysis has been associated with both preserving residual kidney function as well as improving patient quality of life. Barriers to this approach include concerns regarding patient acceptance of dialysis prescription changes, adherence to therapy, and provider factors that would require a restructuring of the current thrice weekly hemodialysis rubric. Candidacy for incremental therapy has shown the best outcomes when urea clearances exceed 3 mL/min and urine volumes are > 500 mL/day, although these measures have been deemed conservative. A significant amount of retrospective and registry data has been supportive of initiating incremental hemodialysis and several pilot studies have shown the feasibility of implementing such an approach. Larger, randomized control trials are needed to fully evaluate safety and efficacy to allow for more widespread acceptance of this patient-centered approach to chronic kidney disease.Keywords: hemodialysis, incremental dialysis, twice-weekly
Details
- Language :
- English
- ISSN :
- 11787058
- Volume :
- ume 15
- Database :
- Directory of Open Access Journals
- Journal :
- International Journal of Nephrology and Renovascular Disease
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.bf268a382a47ffbf5609bb1432b1ef
- Document Type :
- article